Natural history, treatment (tx) patterns, and outcomes in MET dysregulated non-small cell lung cancer (NSCLC) patients (pts)

被引：0
|
作者：
Wolf, J. [1 ]
Baik, C. [2 ]
Heist, R. S. [3 ]
Neal, J. W. [4 ]
Mansfield, A. S. [5 ]
Buettner, R. [6 ]
Davis, K. L. [7 ]
Giovannini, M. [8 ]
Mutebi, A. [9 ]
Awad, M. M. [10 ]
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Washington, Thorac Head & Neck Med Oncol, Seattle, WA 98195 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
[5] Mayo Clin, Med Oncol, Rochester, MN USA
[6] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[7] RTI Hlth Solut, Hlth Econ, Res Triangle Pk, NC USA
[8] Novartis Pharmaceut, Global Clin Dev, E Hanover, NJ USA
[9] Novartis Pharmaceut, US Hlth Econ & Outcomes Res, E Hanover, NJ USA
[10] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403 (PB-06
引用
收藏
页码：E131 / E131
页数：1
相关论文
共 50 条
  • [1] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [2] Biomarker testing and treatment patterns in US patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification
    Ryder, Alex
    Oksen, Dina
    Boutmy, Emmanuelle
    Wang, Yuexi
    Nisbett, Alnecia R.
    Stroh, Christopher
    Johne, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).
    Le, Xiuning
    Paz-Ares, Luis G.
    Van Meerbeeck, Jan
    Viteri, Santiago
    Galvez, Carlos Cabrera
    Baz, David Vicente
    Kim, Young-Chul
    Kang, Jin-Hyoung
    Schumacher, Karl-Maria
    Karachaliou, Niki
    Adrian, Svenja
    Bruns, Rolf
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Treatment outcomes in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification as a secondary oncogenic driver
    Ryder, Alex
    Oksen, Dina
    Boutmy, Emmanuelle
    Ellers-Lenz, Barbara
    Stroh, Christopher
    Karachaliou, Niki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Real-world treatment patterns and outcomes in patients (pts) with advanced, ALK plus non-small cell lung cancer (NSCLC) in Europe
    Stoyanov, N.
    Anderson, D.
    Combest, A.
    Nguyen, B.
    Ognar, R.
    Reitsma, D.
    Capart, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S860 - S860
  • [6] Prognostic significance of aneuploidy in non-small cell lung cancer (NSCLC) patients (pts).
    Dziadziuszko, R
    Wegrzynowicz, E
    Kardas, I
    Limon, J
    Jassem, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 695S - 695S
  • [7] The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis G.
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    Castro, Gilberto
    De Marchi, Pedro
    Felip, Enriqueta
    Goto, Yasushi
    Greystoke, Alastair
    Lu, Shun
    Lim, Darren Wan Teck
    Papadimitrakopoulou, Vassiliki
    Reck, Martin
    Solomon, Benjamin J.
    Spigel, David R.
    Tan, Daniel Shao-Weng
    Thomas, Michael
    Yang, James Chih-Hsin
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [9] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [10] Pilot results of neoadjuvant chemoimmunotherapy (NCIT) in treatment of patients (pts) with non-small cell lung cancer (NSCLC).
    Lazutin, Yury N.
    Kharitonova, Anna Pavlovna
    Zinkovich, Sergei A.
    Vladimirova, Liubov Yu
    Pyltsin, Sergey P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345